{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreif6nuoyjfdgb2lumvk57n4ttmg5ownlti7pi6lsnfhjvpi2owur4q",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mgxk4gyvhhp2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifxsef57qmv3augqhtlt64mvga43g7quhgmvlnclpe46jqfkdniia"
    },
    "mimeType": "image/jpeg",
    "size": 80588
  },
  "path": "/news/2026-03-experimental-alzheimer-drug-reverses-memory.html",
  "publishedAt": "2026-03-13T14:20:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer's disease. Unlike current drugs, which mainly remove beta-amyloid plaques that accumulate in the brain, this new experimental drug reprograms the neuronal epigenome by correcting alterations in gene expression that contribute to the progression of the disease.",
  "title": "Experimental Alzheimer's drug reverses memory loss in mice by reprogramming gene activity"
}